4//SEC Filing
Sandercock Colin 4
Accession 0001193125-25-310067
CIK 0001645460other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 6:54 PM ET
Size
7.8 KB
Accession
0001193125-25-310067
Insider Transaction Report
Form 4
Sandercock Colin
SVP, GENERAL COUNSEL
Transactions
- Award
Stock Option (right to buy)
2025-09-26+30,000→ 30,000 totalExercise: $0.70Exp: 2034-07-23→ Common Stock (30,000 underlying) - Award
Stock Option (right to buy)
2025-12-03+70,000→ 70,000 totalExercise: $0.70Exp: 2024-07-23→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]On July 24, 2024 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria for these shares was deemed satisfied or waived on September 26, 2025 and these shares underlying the option vested.
- [F2]On July 24, 2024 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria for these shares was deemed satisfied or waived on December 3, 2025 and these shares underlying the option vested.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001724870
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 6:54 PM ET
- Size
- 7.8 KB